Acquiring Company
Seraxis
Acquired Company
Sernova Biotherapeutics
GermantownManufacturingBiotechnologyHealth CareBiotechnologyHealth CareTherapeuticsDescription
Seraxis has entered into a merger agreement with Sernova Biotherapeutics to create BetaNova Biotherapeutics, focusing on treatments for type 1 diabetes. The merger is expected to close in November 2026, pending shareholder approval. The combined company will operate research labs and manufacturing capabilities in Germantown. Both companies aim to enhance treatment options for patients with innovative cell-replacement therapies.
Quick answer
Seraxis is acquiring Sernova Biotherapeutics, announced September 8, 2026. Seraxis is based in Germantown, Maryland, United States.
- How much did Seraxis pay for Sernova Biotherapeutics?
- The deal value was not disclosed.
- What does Seraxis do?
- Seraxis is a private biotechnology company launched in 2013.
- Where are Seraxis and Sernova Biotherapeutics based?
- Seraxis is based in Germantown, Maryland, United States.
- Who are the decision-makers at Seraxis?
- Fundz holds 2 contacts at Seraxis. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Therapeutics and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Jazz Pharmaceuticals acquires Actio Biosciences (August 10, 2026)
- Tarsus Pharmaceuticals to acquire Alkeus Pharmaceuticals (August 6, 2026)
- Bristol-Myers acquires Medarex for cancer pipeline (August 2, 2026)
- Curium US Holdings LLC to Acquire Lantheus Holdings, Inc. (October 21, 2026)
- Merck KGaA to acquire Silence Therapeutics for $1.3B, $1.3B (October 19, 2026)
- Valerio Therapeutics finalizes Etherna acquisition (October 12, 2026)
Who to call at Seraxis, and when
When Seraxis changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Seraxis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Seraxis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Seraxis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Seraxis makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Sernova Biotherapeutics?
Sernova Biotherapeutics was acquired by Seraxis, based in Germantown. The deal was reported on September 8, 2026. Seraxis is a private biotechnology company launched in 2013. It focuses on developing innovative treatments for diabetes. The company specializes in stem cell-derived pancreatic islet cells and manufacturing operations. Seraxis is privately held and operates in Manufacturing.
When did Seraxis acquire Sernova Biotherapeutics?
Seraxis's acquisition of Sernova Biotherapeutics was reported on September 8, 2026. Seraxis has entered into a merger agreement with Sernova Biotherapeutics to create BetaNova Biotherapeutics, focusing on treatments for type 1 diabetes. The merger is expected to close in November 2026, pending shareholder approval. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sernova Biotherapeutics do?
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cell-derived cell therapies to create bio-hybrid organs to treat chronic diseases. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.